Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 43

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts

Rothwell, Joseph A., Bešević, Jelena, Dimou, Niki, Breeur, Marie, Murphy, Neil, Jenab, Mazda, Wedekind, Roland, Viallon, Vivian, Ferrari, Pietro, Achaintre, David, Gicquiau, Audrey, Rinaldi, Sabina, Scalbert, Augustin, Huybrechts, Inge, Prehn, Cornelia, Adamski, Jerzy, Cross, Amanda J., Keun, Hector, Chadeau-Hyam, Marc, Boutron-Ruault, Marie-Christine, Overvad, Kim, Dahm, Christina C., Nøst, Therese Haugdahl, Sandanger, Torkjel M., Skeie, Guri, Zamora-Ros, Raul, Tsilidis, Kostas K., Eichelmann, Fabian, Schulze, Matthias B., van Guelpen, Bethany, Vidman, Linda, Sánchez, Maria-José, Amiano, Pilar, Ardanaz, Eva, Smith-Byrne, Karl, Travis, Ruth, Katzke, Verena, Kaaks, Rudolf, Derksen, Jeroen W. G., Colorado-Yohar, Sandra, Tumino, Rosario, Bueno-de-Mesquita, Bas, Vineis, Paolo, Palli, Domenico, Pasanisi, Fabrizio, Eriksen, Anne Kirstine, Tjønneland, Anne, Severi, Gianluca, Gunter, Marc J. · 2023 · BMC Medicine

Abstract

Background: Amino acid metabolism is dysregulated in colorectal cancer patients; however, it is not clear whether pre-diagnostic levels of amino acids are associated with subsequent risk of colorectal cancer. We investigated circulating levels of amino acids in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank cohorts. Methods: Concentrations of 13-21 amino acids were determined in baseline fasting plasma or serum samples in 654 incident colorectal cancer cases and 654 matched controls in EPIC. Amino acids associated with colorectal cancer risk following adjustment for the false discovery rate (FDR) were then tested for associations in the UK Biobank, for which measurements of 9 amino acids were available in 111,323 participants, of which 1221 were incident colorectal cancer cases. Results: Histidine levels were inversely associated with colorectal cancer risk in EPIC (odds ratio [OR] 0.80 per standard deviation [SD], 95% confidence interval [CI] 0.69–0.92, FDR P-value=0.03) and in UK Biobank (HR 0.93 per SD, 95% CI 0.87–0.99, P-value=0.03). Glutamine levels were borderline inversely associated with colorectal cancer risk in EPIC (OR 0.85 per SD, 95% CI 0.75–0.97, FDR P-value=0.08) and similarly in UK Biobank (HR 0.95, 95% CI 0.89–1.01, P=0.09) In both cohorts, associations changed only minimally when cases diagnosed within 2 or 5 years of follow-up were excluded. Conclusions: Higher circulating levels of histidine were associated with a lower risk of colorectal cancer in two large prospective cohorts. Further research to ascertain the role of histidine metabolism and potentially that of glutamine in colorectal cancer development is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-023-02739-4

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 41

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71(3):209–49.
  2. Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW. Colorectal cancer. Lancet. 2005;365(9454):153–65. · DOI · Paper page
  3. Abar L, Vieira AR, Aune D, Sobiecki JG, Vingeliene S, Polemiti E, et al. Height and body fatness and colorectal cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Eur J Nutr. 2018;57(5):1701–20. · DOI
  4. Park JY, Dahm CC, Keogh RH, Mitrou PN, Cairns BJ, Greenwood DC, et al. Alcohol intake and risk of colorectal cancer: results from the UK Dietary Cohort Consortium. Br J Cancer. 2010;103(5):747–56. · DOI
  5. Tabung FK, Brown LS, Fung TT. Dietary Patterns and Colorectal Cancer Risk: a Review of 17 Years of Evidence (2000-2016). Curr Colorectal Cancer Rep. 2017;13(6):440–54. · DOI
  6. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132(6):2208–25. · DOI · Paper page
  7. Gunter MJ, Alhomoud S, Arnold M, Brenner H, Burn J, Casey G, et al. Meeting report from the joint IARC–NCI international cancer seminar series: a focus on colorectal cancer. Ann Oncol. 2019;30(4):510–9. · DOI
  8. Murphy N, Song M, Papadimitriou N, Carreras-Torres R, Langenberg C, Martin RM, et al. Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst. 2022;114(5):740–52. · DOI
  9. Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52(1):15–30. · DOI · Paper page
  10. Goveia J, Pircher A, Conradi L-C, Kalucka J, Lagani V, Dewerchin M, et al. Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med. 2016;8(10):1134–42. · DOI
  11. Geijsen A, van Roekel EH, van Duijnhoven FJB, Achaintre D, Bachleitner-Hofmann T, Baierl A, et al. Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium. Int J Cancer. 2019;146(12):3256. · DOI
  12. Sirniö P, Väyrynen JP, Klintrup K, Mäkelä J, Karhu T, Herzig K-H, et al. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival. Br J Cancer. 2019;120(2):238–46. · DOI
  13. Geijsen A, Brezina S, Keski-Rahkonen P, Baierl A, Bachleitner-Hofmann T, Bergmann MM, et al. Plasma metabolites associated with colorectal cancer: A discovery-replication strategy. Int J Cancer. 2019;145(5):1221–31. · DOI
  14. Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, et al. A Novel Serum Metabolomics-Based Diagnostic Approach for Colorectal Cancer. PLoS One. 2012;7(7):110. · DOI · Paper page
  15. Nishiumi S, Kobayashi T, Kawana S, Unno Y, Sakai T, Okamoto K, et al. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry. Oncotarget. 2017;8(10):17115–26. · DOI
  16. Tan BB, Qiu YP, Zou X, Chen TL, Xie GX, Cheng Y, et al. Metabonomics Identifies Serum Metabolite Markers of Colorectal Cancer. J Proteome Res. 2013;12(6):3000–9. · DOI · Paper page
  17. Erben V, Bhardwaj M, Schrotz-King P, Brenner H. Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review. Cancers. 2018;10(8):246. · DOI
  18. McCullough ML, Hodge RA, Campbell PT, Stevens VL, Wang Y. Pre-Diagnostic Circulating Metabolites and Colorectal Cancer Risk in the Cancer Prevention Study-II Nutrition Cohort. Metabolites. 2021;11(3):156. · DOI
  19. Shu X, Xiang YB, Rothman N, Yu DX, Li HL, Yang G, et al. Prospective study of blood metabolites associated with colorectal cancer risk. Int J Cancer. 2018;143(3):527–34. · DOI
  20. Papadimitriou N, Gunter MJ, Murphy N, Gicquiau A, Achaintre D, Brezina S, et al. Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies. Int J Cancer. 2021;149(9):1659–69. · DOI
  21. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26(Suppl 1):S6–14. · DOI · Paper page
  22. Romisch-Margl W, Prehn C, Bogumil R, Rohring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics. 2012;8(1):133–42. · DOI · Paper page
  23. Rothwell JA, Murphy N, Besevic J, Kliemann N, Jenab M, Ferrari P, et al. Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort. Clin Gastroenterol Hepatol. 2022;20(5):e1061–82. · DOI
  24. Stepien M, Duarte-Salles T, Fedirko V, Floegel A, Barupal DK, Rinaldi S, et al. Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. Int J Cancer. 2016;138(2):348–60. · DOI
  25. Gu JP, Xiao YQ, Shu D, Liang XR, Hu XM, Xie YY, et al. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by H-1-NMR Spectrometry. Dis Markers. 2019;2019:3491852. · DOI
  26. Uchiyama K, Yagi N, Mizushima K, Higashimura Y, Hirai Y, Okayama T, et al. Serum metabolomics analysis for early detection of colorectal cancer. J Gastroenterol. 2017;52(6):677–94. · DOI
  27. Li JK, Li J, Wang H, Qi LW, Zhu YM, Lai MD. Tyrosine and Glutamine-Leucine Are Metabolic Markers of Early-Stage Colorectal Cancers. Gastroenterology. 2019;157(1):257. · DOI
  28. Kuhn T, Floegel A, Sookthai D, Johnson T, Rolle-Kampczyk U, Otto W, et al. Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study. BMC Med. 2016;14:13. https://doi.org/10.1186/s12916-016-0552-3. · DOI · Paper page
  29. Jutel M, Akdis M, Akdis CA. Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy. 2009;39(12):1786–800. · DOI · Paper page
  30. Smolinska S, Jutel M, Crameri R, O'Mahony L. Histamine and gut mucosal immune regulation. Allergy. 2014;69(3):273–81. · DOI · Paper page
  31. Cianchi F, Cortesini C, Schiavone N, Perna F, Magnelli L, Fanti E, et al. The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. Clin Cancer Res. 2005;11(19 Pt 1):6807–15. · DOI
  32. Feng RN, Niu YC, Sun XW, Li Q, Zhao C, Wang C, et al. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia. 2013;56(5):985–94. · DOI · Paper page
  33. Jobard E, Dossus L, Baglietto L, Fornili M, Lecuyer L, Mancini FR, et al. Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort. Br J Cancer. 2021;124(10):1734–43. · DOI
  34. Zhao YQ, Zhao X, Chen V, Feng Y, Wang L, Croniger C, et al. Colorectal cancers utilize glutamine as an anaplerotic substrate of the TCA cycle in vivo. Sci Rep. 2019;9(1):19180. · DOI
  35. Ling HH, Pan Y-P, Fan C-W, Tseng W-K, Huang J-S, Wu T-H, et al. Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer. Nutrients. 2019;11(4):898. · DOI
  36. Liu XR, Zheng Y, Guasch-Ferre M, Ruiz-Canela M, Toledo E, Clish C, et al. High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial. Nutr Metab Cardiovasc Dis. 2019;29(10):1040–9. · DOI
  37. Morze J, Wittenbecher C, Schwingshackl L, Danielewicz A, Rynkiewicz A, Hu FB, et al. Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies. Diabetes Care. 2022;45(4):1013–24. · DOI · Paper page
  38. Watson KM, Gaulke CA, Tsikitis VL. Understanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia. Ann Gastroenterol. 2020;33(3):223–36.
  39. Salahshouri P, Emadi-Baygi M, Jalili M, Khan FM, Wolkenhauer O, Salehzadeh-Yazdi A. A Metabolic Model of Intestinal Secretions: The Link between Human Microbiota and Colorectal Cancer Progression. Metabolites. 2021;11(7):456. · DOI
  40. Iguacel I, Schmidt JA, Perez-Cornago A, Van Puyvelde H, Travis R, Stepien M, et al. Associations between dietary amino acid intakes and blood concentration levels. Clin Nutr. 2021;40(6):3772–9. · DOI
  41. Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, et al. Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples. PLoS One. 2014;9(2):e89728. · DOI · Paper page

Metadata

Authors
Rothwell, J. A., Bešević, J., Dimou, N., Breeur, M., Murphy, N., Jenab, M., Wedekind, R., Viallon, V., Ferrari, P., Achaintre, D., Gicquiau, A., Rinaldi, S., Scalbert, A., Huybrechts, I., Prehn, C., Adamski, J., Cross, A. J., Keun, H., Chadeau-Hyam, M., Boutron-Ruault, M.-C., Overvad, K., Dahm, C. C., Nøst, T. H., Sandanger, T. M., Skeie, G., Zamora-Ros, R., Tsilidis, K. K., Eichelmann, F., Schulze, M. B., van Guelpen, B., Vidman, L., Sánchez, M.-J., Amiano, P., Ardanaz, E., Smith-Byrne, K., Travis, R., Katzke, V., Kaaks, R., Derksen, J. W. G., Colorado-Yohar, S., Tumino, R., Bueno-de-Mesquita, B., Vineis, P., Palli, D., Pasanisi, F., Eriksen, A. K., Tjønneland, A., Severi, G., & Gunter, M. J.
Venue
BMC Medicine
Published
2023-02-28
Volume
21
Issue
1
ISSN
1741-7015
Cited by
43
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. https://app.cochat.ai/papers/10.1186/s12916-023-02739-4
The paper
Rothwell, J. A., Bešević, J., Dimou, N., Breeur, M., Murphy, N., Jenab, M., Wedekind, R., Viallon, V., Ferrari, P., Achaintre, D., Gicquiau, A., Rinaldi, S., Scalbert, A., Huybrechts, I., Prehn, C., Adamski, J., Cross, A. J., Keun, H., Chadeau-Hyam, M., . . . Gunter, M. J. (2023). Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts. BMC Medicine. https://doi.org/10.1186/s12916-023-02739-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.